On-Premises AI Revolutionizes Healthcare, Bridging the Gap Between Innovation and Patient Data Security
admin For over a decade, healthcare organizations have grappled with a fundamental dilemma: how to leverage...
biotech
Moonwalk reloads with $70M and new RNAi prospects for obesity
San Francisco Bay Area-based biotechnology firm Moonwalk Biosciences has announced a significant strategic evolution, securing...
BrainChild Bio Secures $116 Million Series A to Advance Pioneering CAR-T Therapies for Pediatric Brain Cancers
BrainChild Bio, a burgeoning cell therapy developer at the forefront of treating rare and aggressive...
Immunotherapy Transforms Sarcoma Treatment Landscape, Offering New Hope for Patients
Sarcoma, a notoriously rare and complex group of cancers originating in connective tissues, has historically...
Can Viruses Fight Cancer? What Tudriqev Means for Patients With Melanoma
The U.S. Food and Drug Administration (FDA) announced on August 6, 2026, the accelerated approval...
Cancer Research Institute Unveils 2026 CLIP and Technology Impact Awards, Propelling Next-Generation Immunotherapy Innovation
The pursuit of a future free from the specter of cancer hinges on audacious scientific...
The Silent Epidemic: Unraveling the Rising Tide of Lung Cancer in Never-Smokers, a Distinct and Evolving Global Health Challenge
For decades, lung cancer has been inextricably linked to smoking, a perception historically grounded in...
Cancer Research Institute Bolsters Immunotherapy Innovation with $200 Million Investment in Next-Generation Scientists
Tomorrow’s medical revolutions in cancer immunotherapy are meticulously built upon the foundational research conducted by...
Unlocking Ancient Pathways: Dr. Aaron Whiteley Receives CRI STAR Award to Revolutionize Cancer Immunotherapy
The Cancer Research Institute (CRI) has bestowed its prestigious STAR award upon Dr. Aaron Whiteley,...
Pelacarsen Fails to Meet Primary Cardiovascular Endpoint in Landmark Trial, Casting Shadow on Lp(a)-Lowering Strategies
The highly anticipated pivotal Phase 3 clinical trial for pelacarsen, an investigational therapy designed to...
